| |
| [ JPM Week SF 2026 ] |
End Of Slow Science - Inside Pharma's AI-Accelerated Future
|
| With Vivek Adarsh (Founder/CEO, Mithrl), John Cumbers (Founder/CEO, SynBioBeta), Mark Budde (CEO, Plasmidsaurus), Rayyan Sheikh (Innovation Leader, Roche), Morten Sogaard (SVP Innovation, Astellas). |
| Venue, 100 Montgomery St, 12th Fl, San Francisco |
|
Jan 14 (Wed) , 2026 @ 05:00 PM
| |
FREE |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Join us on January 14th for JPM Healthcare Satellite Happy Hour & Panel Discussions on AI & Biopharma Innovation.
Speakers for our two panel sessions:
Vivek Adarsh, Co-Founder & CEO, Mithrl
Mark Budde, Co-Founder & CEO, Plasmidsaurus
Rayyan Sheikh, Discovery & Innovation Research Leader, Roche
Morten Sogaard, SVP Innovation, Astellas
Uli Stilz, Global BioPharma leader & Board Member
Hinco Gierman, CSO, Elephas
Steven Henck, VP & NGS Fellow, Danaher (IDT)
Jimmy Lin, CSO, Freenome
Mia Nease, SVP Commercial, DNAnexus
Gordon Sanghera, Founder & CEO, Oxford Nanopore Technologies
Christopher Szeto, Snr. Director of Discovery Bioinformatics, Exelixis
Moderator: John Cumbers, Founder & CEO, SynBioBeta
Who: A must-attend for scientists, biotech innovators, pharma leaders, & investors who want an edge in shaping, & capitalizing on the next wave of therapeutic discovery.
Leaders spanning pharma, biotech, & AI will share perspectives on what will propel & constrain the next therapeutic discovery era. Expect a dynamic debate with experts & the chance to connect, all to a backdrop of gourmet food & craft beverages.
Agenda:
5-5:30 opening reception
5:30-6:00 first panel
6:00-6:30 networking break
6:30-7 second panel
7-8 networking happy hour
You are welcome to share this with your network. This event is complimentary (requests will be reviewed for domain relevance to ensure an optimal networking experience for all). To ensure your approval, please provide your work email. All attendees must be registered in advance for event entrance.
This event is hosted by Mithrl. Co-sponsors making this event possible are:
Integrated DNA Technologies (IDT)
Oxford Nanopore Technologies (ONT)
Plasmidsaurus
DNAnexus
Goodwin
We hope you will join us!
Mithrl is the Life Sciences AI Co-Scientist that serves to complement & unify pharma discovery teams. Within one platform, bench scientists & computational biologists accelerate analyses & contextualize results within comprehensive bio-insights. With Mithrl, scientists work to discover new biomarkers, identify new therapeutic targets, understand mechanisms of action, & ultimately create new IP opportunities. Mithrl adapts & responds to user-prompted or Mithrl-suggested questions to take discovery further, faster, all in a single, reproducible environment. Follow Mithrl on social: linkedin.com/company/mithrl-ai & x.com/mithrl_ai
About Integrated DNA Technologies
Building from a strong foundation of innovation, expertise, & reliability, Integrated DNA Technologies (IDT) has evolved from an oligo manufacturer to a leading genomics provider. We work shoulder-to-shoulder with scientific & global health partners to enable genomics breakthroughs at scale. Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our ongoing commitment to a healthier, brighter future for all.
For more information about IDT, visit www.idtdna.com & follow the company on LinkedIn, X, Facebook, YouTube, & Instagram.
Disclaimer: RUO - For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications & does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products & any associated regulatory or legal obligations.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible & affordable molecular analysis. The first application is DNA/RNA sequencing, & the technology is in development for the analysis of other types of molecules including proteins. The technology is used in more than 125 countries to understand & characterise the biology of humans & diseases such as cancer, plants, animals, bacteria, viruses, & whole environments.
For more, visit: https://nanoporetech.com/
About Plasmidsaurus
Plasmidsaurus is on a mission to accelerate science with the best sequencing. The company's sequencing services, spanning whole plasmids, RNA-seq, amplicons, whole genomes, AAV, & microbiomes, are used daily by thousands of innovators, including Nobel Prize winners, dynamic biotech startups, pharmaceutical companies, research labs, & DIY biohackers. Plasmidsaurus's global network of labs operates day & night to enable world-changing discoveries. For more, visit: plasmidsaurus.com
About DNAnexus
DNAnexus is a cloud-based data platform that enables organizations to securely manage, analyze, & collaborate on genomic & biomedical data at scale. It provides tools & infrastructure for running bioinformatics workflows, integrating multi-omics & clinical data, & meeting strict regulatory & compliance requirements, helping researchers, biotechs, & pharma teams turn complex biological data into actionable insights.
About Goodwin
Goodwin is a global law firm headquartered in the United States with more than 2,000 lawyers across offices in North America, Europe, & Asia, offering complex transactional, litigation, regulatory, & advisory legal services. The firm focuses on key industries including private equity, technology, life sciences, real estate, financial services, & investment funds, helping companies, investors, & institutions navigate legal challenges, close major deals, manage risk, & achieve strategic goals.
Please note that photographs & footage will be taken throughout the event. These will be used by all co-sponsors for marketing & publicity in our publications, on our website & in social media or in any third-party publication. Please contact the event host if you have any concerns or if you wish to be exempted from this activity.
|
|
|
|
|
|
|
|
